Precision-oncology biotech using Click-to-Release chemistry for targeted ADCs.
| Date | Round | Amount |
|---|---|---|
| Jun 2023 | Series A Dutch precision-medicine biotech Tagworks Pharmaceuticals raised a USD65M Series A led by Ysios Capital and Gilde Healthcare, with Novartis Venture Fund, NEA and Lightstone, for its Click-to-Release cancer therapies. | $59.5M |